Qu Y - Search Results

1

Oleanolic acid blocks the purine salvage pathway for cancer therapy by inactivating SOD1 and stimulating lysosomal proteolysis.

Liu D, Jin X, Yu G, Wang M, Liu L, Zhang W, Wu J, Wang F, Yang J, Luo Q, Cai L, Yang X, Ke X, Qu Y, Xu Z, Jia L, Chen WL. Liu D, et al. Among authors: qu y. Mol Ther Oncolytics. 2021 Aug 28;23:107-123. doi: 10.1016/j.omto.2021.08.013. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34703880 Free PMC article.

2

Small molecule induces Wnt asymmetry in cancer.

Qu Y, Kalland KH, Ke X. Qu Y, et al. Cell Cycle. 2017 Jan 17;16(2):141-142. doi: 10.1080/15384101.2016.1235850. Epub 2016 Sep 29. Cell Cycle. 2017. PMID: 27687486 Free PMC article. No abstract available.

3

Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.

Qu Y, Olsen JR, Yuan X, Cheng PF, Levesque MP, Brokstad KA, Hoffman PS, Oyan AM, Zhang W, Kalland KH, Ke X. Qu Y, et al. Nat Chem Biol. 2018 Jan;14(1):94-101. doi: 10.1038/nchembio.2510. Epub 2017 Oct 30. Nat Chem Biol. 2018. PMID: 29083417

4

Rapid characterization of chemical constituents and metabolites of Qi-Jing-Sheng-Bai granule by using UHPLC-Q-TOF-MS.

Wu R, Lin S, Wang J, Tian S, Ke X, Qu Y, Tian X, Qi X, Ye J, Zhang W. Wu R, et al. Among authors: qu y. J Sep Sci. 2018 May;41(9):1960-1972. doi: 10.1002/jssc.201701310. Epub 2018 Feb 23. J Sep Sci. 2018. PMID: 29385310

5

Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.

Wang B, Tian T, Kalland KH, Ke X, Qu Y. Wang B, et al. Among authors: qu y. Trends Pharmacol Sci. 2018 Jul;39(7):648-658. doi: 10.1016/j.tips.2018.03.008. Epub 2018 Apr 17. Trends Pharmacol Sci. 2018. PMID: 29678298 Review.

6

Is β-Catenin a Druggable Target for Cancer Therapy?

Cui C, Zhou X, Zhang W, Qu Y, Ke X. Cui C, et al. Among authors: qu y. Trends Biochem Sci. 2018 Aug;43(8):623-634. doi: 10.1016/j.tibs.2018.06.003. Epub 2018 Jul 2. Trends Biochem Sci. 2018. PMID: 30056837 Review.

7

Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.

Huang P, Yan R, Zhang X, Wang L, Ke X, Qu Y. Huang P, et al. Among authors: qu y. Pharmacol Ther. 2019 Apr;196:79-90. doi: 10.1016/j.pharmthera.2018.11.008. Epub 2018 Nov 20. Pharmacol Ther. 2019. PMID: 30468742 Review.

8

Tanshinones induce tumor cell apoptosis via directly targeting FHIT.

Zhou X, Pan Y, Wang Y, Wang B, Yan Y, Qu Y, Ke X. Zhou X, et al. Among authors: qu y. Sci Rep. 2021 Jun 9;11(1):12217. doi: 10.1038/s41598-021-91708-z. Sci Rep. 2021. PMID: 34108553 Free PMC article.

9

Small molecule targeting topoisomerase 3β for cancer therapy.

Zhang X, Wang L, Zhang Q, Lyu S, Zhu D, Shen M, Ke X, Qu Y. Zhang X, et al. Among authors: qu y. Pharmacol Res. 2021 Dec;174:105927. doi: 10.1016/j.phrs.2021.105927. Epub 2021 Nov 2. Pharmacol Res. 2021. PMID: 34740818

10

Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2.

Yan R, Zhu H, Huang P, Yang M, Shen M, Pan Y, Zhang C, Zhou X, Li H, Ke X, Zhang W, Hao P, Qu Y. Yan R, et al. Among authors: qu y. Cell Rep. 2022 Feb 1;38(5):110319. doi: 10.1016/j.celrep.2022.110319. Cell Rep. 2022. PMID: 35108540 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,387 results

Search Page

Filters